文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性病成人宽松与保守氧疗的死亡率和发病率比较(IOTA):系统评价与荟萃分析

Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.
PubMed 文献 · Lancet · 2018-04-26
一句话结论高质量证据显示,急性病成人宽松氧疗较保守氧疗增加住院、30天及最长随访死亡率,且不改善其他重要结局;SpO2超过94-96%时补充氧可能不利,支持保守给氧。

该系统评价与荟萃分析纳入25项随机对照试验共16037例急性病成人(脓毒症、危重症、卒中、创伤、心肌梗死、心脏骤停及急诊手术后)。比较宽松与保守氧疗策略,宽松组住院死亡率(RR 1.21,95%CI 1.03-1.43)、30天死亡率(RR 1.14,95%CI 1.01-1.29)及最长随访死亡率(RR 1.10,95%CI 1.00-1.20)均升高,证据质量高(I2=0%)。 morbidity结局两组相似。结论支持保守给氧,SpO2超过94-96%时补充氧可能不利。

要点

  • 宽松氧疗较保守氧疗增加住院死亡率(RR 1.21,95%CI 1.03-1.43,I2=0%,高质量证据)。
  • 宽松氧疗增加30天死亡率(RR 1.14,95%CI 1.01-1.29)及最长随访死亡率(RR 1.10,95%CI 1.00-1.20)。
  • morbidity结局(最长随访残疾、医院获得性肺炎、任何医院获得性感染、住院时间)两组相似。
  • 各试验中位基线SpO2为96%(范围94-99%,IQR 96-98%),补充氧在SpO2超过94-96%范围时可能不利。
  • 结果经试验序贯、亚组和敏感性分析稳健,支持保守给氧策略。

适用人群与场景

  • 急性病成人(年龄≥18岁),包括脓毒症、危重症、卒中、创伤、心肌梗死、心脏骤停及急诊手术后患者。
  • 排除:仅限慢性呼吸系统疾病或精神疾病患者、接受体外生命支持患者、接受高压氧治疗或择期手术患者。

研究设计与关键结果

  • 研究类型:系统评价与荟萃分析(IOTA),纳入25项随机对照试验,共16037例急性病成人。
  • 干预与对照:宽松氧疗策略 vs 保守氧疗策略;各试验中位基线SpO2为96%(范围94-99%,IQR 96-98%)。
  • 主要终点:宽松组较保守组住院死亡率升高(RR 1.21,95%CI 1.03-1.43,I2=0%,高质量证据)。
  • 主要终点:30天死亡率升高(RR 1.14,95%CI 1.01-1.29,I2=0%,高质量证据);最长随访死亡率升高(RR 1.10,95%CI 1.00-1.20,I2=0%,高质量证据)。
  • 次要终点: morbidity结局(最长随访残疾、医院获得性肺炎、任何医院获得性感染、住院时间)两组相似。
  • 结果经试验序贯、亚组和敏感性分析稳健。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析,采用GRADE方法评估证据质量。
  • 证据质量:死亡率结局为高质量证据(I2=0%)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在急性病成人中,高质量证据显示宽松氧疗增加死亡率而不改善其他患者重要结局,补充氧在SpO2超过94-96%范围时可能不利;这些结果支持保守给氧。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Supplemental oxygen is often administered liberally to acutely ill adults, but the credibility of the evidence for this practice is unclear. We systematically reviewed the efficacy and safety of liberal versus conservative oxygen therapy in acutely ill adults.

METHODS: In the Improving Oxygen Therapy in Acute-illness (IOTA) systematic review and meta-analysis, we searched the Cochrane Central Register of Controlled Trials, MEDLINE, Embase, HealthSTAR, LILACS, PapersFirst, and the WHO International Clinical Trials Registry from inception to Oct 25, 2017, for randomised controlled trials comparing liberal and conservative oxygen therapy in acutely ill adults (aged ≥18 years). Studies limited to patients with chronic respiratory diseases or psychiatric disease, patients on extracorporeal life support, or patients treated with hyperbaric oxygen therapy or elective surgery were excluded. We screened studies and extracted summary estimates independently and in duplicate. We also extracted individual patient-level data from survival curves. The main outcomes were mortality (in-hospital, at 30 days, and at longest follow-up) and morbidity (disability at longest follow-up, risk of hospital-acquired pneumonia, any hospital-acquired infection, and length of hospital stay) assessed by random-effects meta-analyses. We assessed quality of evidence using the grading of recommendations assessment, development, and evaluation approach. This study is registered with PROSPERO, number CRD42017065697.

FINDINGS: 25 randomised controlled trials enrolled 16 037 patients with sepsis, critical illness, stroke, trauma, myocardial infarction, or cardiac arrest, and patients who had emergency surgery. Compared with a conservative oxygen strategy, a liberal oxygen strategy (median baseline saturation of peripheral oxygen [SpO2] across trials, 96% [range 94-99%, IQR 96-98]) increased mortality in-hospital (relative risk [RR] 1·21, 95% CI 1·03-1·43, I2=0%, high quality), at 30 days (RR 1·14, 95% CI 1·01-1·29, I2=0%, high quality), and at longest follow-up (RR 1·10, 95% CI 1·00-1·20, I2=0%, high quality). Morbidity outcomes were similar between groups. Findings were robust to trial sequential, subgroup, and sensitivity analyses.

INTERPRETATION: In acutely ill adults, high-quality evidence shows that liberal oxygen therapy increases mortality without improving other patient-important outcomes. Supplemental oxygen might become unfavourable above an SpO2 range of 94-96%. These results support the conservative administration of oxygen therapy.

来源:Lancet,查看原文。版权归原作者所有。

参考来源

  1. Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet. 2018. PMID: 29726345. doi:10.1016/S0140-6736(18)30479-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。